HomeTOP STORIESInnate Pharma S.A. GAAP EPS of -€0.25, revenue of €4.9M Innate Pharma S.A. GAAP EPS of -€0.25, revenue of €4.9M By rogerjudd September 17, 2025 FacebookTwitterPinterestWhatsApp Post Content Previous articleSensorion reports 1H resultsNext articleKohl’s rallies to a 2025 high as its hot streak continues latest articles The inflation process has shifted even as headline CPI declined – Federal Reserve Cerrado Gold reports Q4 results As H-1B Visa Program Changes, Skilled Foreign Workers Consider Leaving U.S. They Get Drunk Without Drinking: What It’s Like to Have Auto-brewery Syndrome Parents Who Borrowed for Children’s College Face Looming Deadline Watch: Artemis II’s journey so far… in 85 seconds explore more The inflation process has shifted even as headline CPI declined – Federal Reserve Cerrado Gold reports Q4 results As H-1B Visa Program Changes, Skilled Foreign Workers Consider Leaving U.S. They Get Drunk Without Drinking: What It’s Like to Have Auto-brewery Syndrome Parents Who Borrowed for Children’s College Face Looming Deadline Watch: Artemis II’s journey so far… in 85 seconds
